Sun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It also offers diversification into new segments like women’s health and biosimilars. The acquisition is expected to strengthen Sun Pharma’s position for future growth. Managing integration and debt will be key.Read More

Indian stock markets ended a three-day losing streak with a gain of 0.8 percent on Monday. This rise followed positive movements in Asian markets. Investors showed buying interest in heavyweights like Reliance Industries and Sun Pharmaceuticals. All sectoral indices closed higher. The India VIX volatility index saw a decrease. Foreign portfolio investors sold shares, while...Read More

Axis Bank shares fell 3% despite analysts maintaining a positive outlook, with 94% recommending ‘Buy’. The bank’s loan growth was strong, but provisions for the West Asia conflict rose significantly, impacting performance. Management’s cautious approach to strengthening provisions, while improving asset quality, led to higher credit costs.Read More

Kotak Mahindra Asset Management Co. has approached the Supreme Court challenging a Securities Appellate Tribunal order that upheld SEBI’s findings against it regarding investments made by six fixed maturity plans in Essel Group companies. The tribunal had previously confirmed SEBI’s penalties for regulatory lapses and delayed payouts, though it set aside a fee disgorgement order.Read More

Temasek Holdings-backed OnEMI Technology Solutions, operating the digital lending platform Kissht, has set its IPO price band at ₹162-171 per share. The ₹926 crore offering, open from April 30 to May 5, includes a fresh issue of ₹850 crore and an offer for sale. Several prominent financial institutions are managing the issue.Read More

Vedanta’s stock has seen a dip following the announcement of its demerger into five listed entities, aimed at reducing the conglomerate discount. Investors looking to benefit from the split must purchase shares by April 29. The demerger is anticipated to unlock significant valuation upside, with combined post-demerger valuations projected to rise by 14%.Read More

Banks faced significant trading losses in Q4 2025-26 due to rising interest rates and forex market corrections, impacting profitability. The Iran war has also clouded the business growth outlook, with lenders becoming cautious and focusing on portfolio protection over expansion. Credit growth is expected to decelerate.Read More

The Reserve Bank of India is bringing offshore rupee derivative trades under its regulatory watch. Authorized dealers must now report over-the-counter FX contracts, both deliverable and non-deliverable, to enhance oversight of price discovery. This move aims to curb market volatility. A phased implementation starting July 2027 will allow banks time to comply.Read More

Dozens of companies are delaying IPO plans due to volatile investor sentiment and geopolitical concerns, impacting market valuations. While the year began strong, a recent slowdown has seen a significant drop in new listings. Experts anticipate a market pickup in June, contingent on global stability and a resolution of valuation mismatches between issuers and investors.Read More